This website is intended for UK healthcare professionals only.

Introducing the Similac®
Hypoallergenic Formula Range

Designed to help you support the immune needs of infants requiring hypoallergenic formula*

Alimentum® and EleCare® are the first and only hypoallergenic formulas to contain 2’-FL in the UK

Alimentum®

For mild-to-moderate CMA and other conditions where an extensively hydrolysed formula is indicated

image-alimentum

Find out more about Alimentum arrow

EleCare®

For severe CMA and/or multiple food allergies, and other conditions where an amino acid-based formula is indicated

image-ele-care

Find out more about EleCare arrow

icon-shield

Help support the immune system in the gut and beyond§1–3

icon-circle-arrow

Support healthy growth and symptom resolution¶4–10

icon-shield-tick

Trusted by parents and healthcare professionals8,11–13

Abbott has dedicated over two decades of clinical research to HMOs14

timeline-2-x
shrink-close shrink-open key-timeline

IMPORTANT NOTICE: Breastfeeding is best for infants and is recommended for as long as possible during infancy. Alimentum and EleCare are infant formulas for special medical purposes and should only be used under the recommendation or guidance of a healthcare professional.

*The International Milk Allergy in Primary Care (iMAP) guideline recommends breastfeeding as the first-line option in infants with CMA.15
The 2'-FL (2'-fucosyllactose) used in this formula is biosynthesised and structurally identical to the human milk oligosaccharide (HMO) 2'-FL, found in most mothers' breast milk.1
MIMS. December 2020.
§Studies conducted in healthy-term infants consuming standard Similac formula with 2’-FL (not Alimentum or EleCare), compared with control formula without 2’-FL.
Parent reports from a single-arm study, where all infants were consuming an extensively hydrolysed formula before being switched to Alimentum with 2’-FL for 60 days. After 7 days of switching to Alimentum with 2’-FL, the majority of parents reported that the following symptoms had improved or resolved: 84% of infants with constipation, 71% of infants with eczema, 100% of infants with vomiting.8

CMA: cow’s milk allergy; HMO: human milk oligosaccharide.

References

UK-SIMILAC-2000016 December 2020